BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11119967)

  • 1. Percutaneous fine-needle ethanol injection in a renal transplant patient with enlarged parathyroid glands.
    Dwarakanathan R; Maracir S; Chin SL
    Transplant Proc; 2000 Nov; 32(7):1850-1. PubMed ID: 11119967
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of post-transplant hyperparathyroidism treated with ethanol injection.
    Ohta T; Sakano T; Fuchinoue S; Tsuji T; Tanabe K; Hattori M; Nagafuchi H; Shiraga H; Kihara H; Kinoshita Y; Ito K
    Pediatr Nephrol; 2002 Apr; 17(4):236-8. PubMed ID: 11956872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation.
    Borchhardt KA; Heinzl H; Mayerwöger E; Hörl WH; Haas M; Sunder-Plassmann G
    Transplantation; 2008 Oct; 86(7):919-24. PubMed ID: 18852656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cinacalcet-associated graft dysfunction and nephrocalcinosis in a kidney transplant recipient.
    Peng LW; Logan JL; James SH; Scott KM; Lien YH
    Am J Med; 2007 Sep; 120(9):e7-9. PubMed ID: 17765036
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-surgical treatment of primary hyperparathyroidism.
    Rizzoli R; Ammann P
    Acta Endocrinol (Copenh); 1993 Nov; 129(5):375-6. PubMed ID: 8279216
    [No Abstract]   [Full Text] [Related]  

  • 6. Results of ultrasonically guided percutaneous ethanol injection into parathyroid adenomas in primary hyperparathyroidism.
    Vergès BL; Cercueil JP; Jacob D; Vaillant G; Brun JM; Putelat R
    Acta Endocrinol (Copenh); 1993 Nov; 129(5):381-7. PubMed ID: 8279218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid suppressibility in hyperparathyroidism due to chronic renal failure: studies with autotransplanted parathyroid tissue.
    Born W; Dambacher MA; Meyrier A; Ardaillou R; Fischer JA
    Clin Endocrinol (Oxf); 1982 Oct; 17(4):333-43. PubMed ID: 6754143
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in blood pressure and renal function after subtotal parathyroidectomy in renal transplant patients presenting persistent hypercalcemic hyperparathyroidism.
    Rostaing L; Moreau-Gaudry X; Baron E; Cisterne JM; Bernadet-Monrozies P; Durand D
    Transplant Proc; 1997; 29(1-2):204-6. PubMed ID: 9122964
    [No Abstract]   [Full Text] [Related]  

  • 9. Tertiary hyperparathyroidism treated by ultrasonically guided percutaneous fine-needle ethanol injection.
    Cintin C; Karstrup S; Ladefoged SD; Joffe P
    Nephron; 1994; 68(2):217-20. PubMed ID: 7830859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural History of Serum Calcium and Parathyroid Hormone Following Renal Transplantation.
    Al-Moasseb Z; Aitken E
    Transplant Proc; 2016 Dec; 48(10):3285-3291. PubMed ID: 27931570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Percutaneous transthyroidal instillation treatment of parathyroid adenoma with ethanol in primary hyperparathyroidism].
    Müller-Gärtner HW; Beil FU; Schneider C; Ringe JD; Greten H
    Dtsch Med Wochenschr; 1987 Sep; 112(38):1459-61. PubMed ID: 3622294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent primary hyperparathyroidism: successful ultrasound-guided percutaneous ethanol ablation of an occult adenoma.
    Charboneau JW; Hay ID; van Heerden JA
    Mayo Clin Proc; 1988 Sep; 63(9):913-7. PubMed ID: 3045436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of persistent hyperparathyroidism in renal transplant patients with cinacalcet improves control of blood pressure.
    Carrasco FR; Pérez-Flores I; Calvo N; Ridao N; Sánchez A; Barrientos
    Transplant Proc; 2009; 41(6):2385-7. PubMed ID: 19715927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can successful renal transplantation resolve secondary hyper-parathyroidism?
    Koyama Y; Miyazato T; Hatano T; Ogawa Y
    Transplant Proc; 1996 Jun; 28(3):1644-5. PubMed ID: 8658819
    [No Abstract]   [Full Text] [Related]  

  • 15. Parathyroid function after kidney allografting.
    Tajima A; Ishikawa A; Ohta N; Suzuki K; Kawabe K; Aso Y
    Transplant Proc; 1996 Jun; 28(3):1629-30. PubMed ID: 8658814
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence and risk factors for tertiary hyperparathyroidism in kidney transplant recipients.
    Sutton W; Chen X; Patel P; Karzai S; Prescott JD; Segev DL; McAdams-DeMarco M; Mathur A
    Surgery; 2022 Jan; 171(1):69-76. PubMed ID: 34266650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Use of Cinacalcet in Kidney Transplant Recipients With Hypercalcemic Secondary Hyperparathyroidism: A Single-Center Prospective Study.
    Zavvos V; Fyssa L; Papasotiriou M; Papachristou E; Ntrinias T; Savvidaki E; Goumenos DS
    Exp Clin Transplant; 2018 Jun; 16(3):287-293. PubMed ID: 29108515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumocystis carinii pneumonia with hypercalcemia and suppressed parathyroid hormone levels in a renal transplant patient.
    Hung YM
    Transplantation; 2006 Feb; 81(4):639. PubMed ID: 16495820
    [No Abstract]   [Full Text] [Related]  

  • 19. Resolution of hyperparathyroidism, renal osteodystrophy and metastatic calcification after renal homotransplantation.
    Alfrey AC; Jenkins D; Groth CG; Schorr WS; Gecelter L; Ogden DA
    N Engl J Med; 1968 Dec; 279(25):1349-56. PubMed ID: 4880442
    [No Abstract]   [Full Text] [Related]  

  • 20. Percutaneous ultrasound-guided chemical parathyroid ablation for treatment of primary hyperparathyroidism in dogs.
    Long CD; Goldstein RE; Hornof WJ; Feldman EC; Nyland TG
    J Am Vet Med Assoc; 1999 Jul; 215(2):217-21. PubMed ID: 10416475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.